3/6/62 â 2/25/21
It is with a very heavy heart that we announce the passing of Blas Mesa on Feb. 25, 2021 from a battle with cancer. Blas is predeceased by his parents, and three siblings: Abe Wetzler, Rosa Mesa and Hildelisa Mesa. He is survived by his best friend, Jack Wetzler, and other friends of more than 25 years: Eileen Wetzler, Myke McCoy, Dennis Mikkelsen and Katrina Birt, as well as many more friends too numerous to list. He is also survived by five siblings: Josefina Peralpa, Hortensia Mesa, Anisia Barroso, Vikky Lopez and Dorian Mesa; numerous nieces and nephews; primos Minerva, Francisco, Anicia and Aneisy and so many more family members still living in Cuba. And, the loves of his life, Boston Terriers, Rhonda and Snoopy miss him so much.
Staff Reports
Mar 2, 2021
Colquitt Regional Medical Center will cut the ribbon on its new radiation oncology unit at the Edwards Cancer Center Wednesday. Pictured is the state-of-the-art linear accelerator, the Elekta Versa HD, which is housed in the treatment chamber of the new unit. This technology is a revolutionary radiation treatment system designed to improve cancer patient care and is now available at the Edwards Cancer Center, the hospital said. Colquitt Regional Medical Center
MOULTRIE, Ga. â Colquitt Regional Medical Center is prepared to expand its oncology offerings this week to help local cancer patients fight their disease.
The Edwards Cancer Center at Colquitt Regional will celebrate its new radiation oncology unit with a virtual ribbon cutting at 10 a.m. Wednesday, March 3. The ceremony will be streamed live on the Colquitt Regional Facebook page.
Mar 3, 2021 2:00pm A team led by scientists at China Medical University successfully targeted a section of the IL-17RB protein to shrink tumors in mice with pancreatic cancer. (By Manu5 (http://www.scientificanimations.com/wiki-images/) [CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons)
Pancreatic cancer is highly aggressive, and it s typically diagnosed late, resulting in few effective treatment options. Researchers led by China Medical University have found a possible way to inhibit this deadly tumor by targeting a molecular loophole in a cancer-promoting protein.
The protein is interleukin-17 receptor B (IL-17RB), and the team discovered that a small piece of synthetic peptide placed on the flexible loop region of the protein could impede its pro-cancer signaling. In a mouse model of pancreatic cancer, the peptide reduced tumor metastases and extended survival.
Many rural areas identify with many barriers in their community, such as transportation, technology access, human factors, and the design of the health care model.
Photo by Samuel Corum/Getty Images This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Biden is starting his administration s efforts to fast-track cancer-treatment research.
He held a meeting Wednesday with a bipartisan group of lawmakers to discuss his plans.
Biden s nominee to lead White House science policy, Eric Lander, is expected to lead the effort.
President Joe Biden has jump-started efforts to bolster research on cancer treatments and cures, picking up from where he left off as Barack Obama s vice president.
The issue has been a priority for Biden, whose son Beau Biden died of brain cancer in 2015.